Q&A: Forbion Capital Partners' Sander Slootweg
Life-sciences-focused venture firm Forbion Capital Partners recently held a €360m final close for its fourth flagship fund, surpassing its initial hard-cap of €350m. Managing partner Sander Slootweg speaks to Francesca Veronesi about the fundraising process, the firm's 'build' strategy and the European life sciences venture market
More on Benelux
Waterland invests in Intracto
GP draws capital from its €2bn Waterland Private Equity Fund VII, which closed in 2017
EQT Ventures co-leads €20m round for Dott
Other investors include Axel Springer Digital Ventures, DN Capital and Felix Capital
Q&A: Sebastien Canderle
Unquote catches up with Sebastien Canderle to discuss his latest book and his views on private equity
Rabo PE backs V&S Food Specialist
GP buys a 40% stake via Rabo Pariticipaties in Netherlands-based V&S Food Specialist
Latest News
Siparex et al. back Mathevon in SBO
Transaction sees Aquasourca, Garibaldi Participations, Esfin Gestion and BPI France exit
Adaxtra et al. back Groupe Asia in MBO
GPs invest in tour operator Groupe Asia alongside the CEO and the Chantraine family
AnaCap exits AssurOne
Deal ends a four-year holding period for AnaCap, which bought AssurOne from Seventure and BPI France
Andera sells Scalian to Cobepa – reports
Andera wholly owns the engineering consultancy, having acquired stakes in 2015 and early 2018